These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14559371)

  • 61. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 62. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 63. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 65. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Million Women Study and breast cancer.
    Speroff L
    Maturitas; 2003 Sep; 46(1):1-6. PubMed ID: 12963165
    [No Abstract]   [Full Text] [Related]  

  • 67. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 68. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 69. The breast and the menopause.
    Wren BG
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):433-47. PubMed ID: 8931904
    [No Abstract]   [Full Text] [Related]  

  • 70. Progestins and breast cancer.
    Eden J
    Am J Obstet Gynecol; 2003 May; 188(5):1123-31. PubMed ID: 12748456
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I
    Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Why jump on estrogen?
    Gardner B
    Ann Surg Oncol; 2000 Apr; 7(3):169-70. PubMed ID: 10791843
    [No Abstract]   [Full Text] [Related]  

  • 74. Hormone replacement and cancer.
    Barrett-Connor E
    Br Med Bull; 1992 Apr; 48(2):345-55. PubMed ID: 1450874
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hormone replacement therapy for women with a past history of breast cancer.
    Stoll BA
    Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):309-12. PubMed ID: 2278887
    [No Abstract]   [Full Text] [Related]  

  • 76. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
    Campagnoli C; Clavel-Chapelon F; Kaaks R; Peris C; Berrino F
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):95-108. PubMed ID: 15908197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hormone replacement therapy and breast cancer.
    Kenemans P; Stampfer M
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):1-4. PubMed ID: 8789741
    [No Abstract]   [Full Text] [Related]  

  • 78. Menopausal hormone therapy: a paradigm shift?
    Liu JH
    Fertil Steril; 2003 Sep; 80(3):494-5. PubMed ID: 12969685
    [No Abstract]   [Full Text] [Related]  

  • 79. Hormone replacement therapy and breast cancer: an overview.
    Theriault RL
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
    [No Abstract]   [Full Text] [Related]  

  • 80. An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk.
    Green LE; Dinh TA; Smith RA
    Comput Math Methods Med; 2012; 2012():792375. PubMed ID: 22291855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.